|
Re: eGFR and Cognition?
|
3
|
Resverlogix Corp.
|
Nov 23, 2019 04:49PM
|
|
Re: eGFR and Cognition?
|
1
|
Resverlogix Corp.
|
Nov 25, 2019 08:03AM
|
|
Re: eGFR data question from IR
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 06:44PM
|
|
Re: eGFR.....
|
2
|
Resverlogix Corp.
|
Feb 09, 2020 01:26PM
|
|
Re: Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
|
1
|
Resverlogix Corp.
|
Jun 10, 2020 09:08AM
|
|
Re: Epigenetics
|
1
|
Zenith Epigenetics
|
Jan 24, 2023 09:31AM
|
|
Re: Epigenetics
|
3
|
Resverlogix Corp.
|
Feb 14, 2022 06:07AM
|
|
Re: Epigentic headline:
|
3
|
Resverlogix Corp.
|
May 01, 2024 02:01PM
|
|
Re: Estimated Glomerular Filtration Rate
|
1
|
Resverlogix Corp.
|
Nov 17, 2019 04:54PM
|
|
Re: Estimated Glomerular Filtration Rate
|
2
|
Resverlogix Corp.
|
Nov 17, 2019 05:22PM
|
|
Re: Estimated Glomerular Filtration Rate
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 06:45PM
|
|
Re: Even DM must take PCR tests (at least up to Feb 28)
|
|
Resverlogix Corp.
|
Mar 03, 2022 05:53AM
|
|
Re: Eversana ValuationCaseStudy
|
1
|
Resverlogix Corp.
|
Jan 08, 2022 08:06AM
|
|
Re: Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 09, 2022 12:20PM
|
|
Re: Eversana ValuationCaseStudy
|
2
|
Resverlogix Corp.
|
Jan 10, 2022 08:36AM
|
|
Re: everything r v x is down 4% to around 24%
|
1
|
Resverlogix Corp.
|
Jan 27, 2021 03:29PM
|
|
Re: Evidently that hedge fund....
|
1
|
Resverlogix Corp.
|
Jun 12, 2020 03:19PM
|
|
Re: Excerpt of a recent Bloomberg article......
|
4
|
Resverlogix Corp.
|
Jan 15, 2020 01:24PM
|
|
Re: Exempt
|
2
|
Resverlogix Corp.
|
Mar 24, 2021 04:03PM
|
|
Re: Exempt
|
3
|
Resverlogix Corp.
|
Mar 24, 2021 05:58PM
|
